Merck Raises Zocor Projections For 2005 Due To Less Than Expected Competition
Merck believes Zocor (simvastatin) will perform better than initially projected in 2005 based mostly on less than expected competition in the market
Merck believes Zocor (simvastatin) will perform better than initially projected in 2005 based mostly on less than expected competition in the market